Researchers have proved that high DDX1 expression is associated with improvement in local control, distant metastatic-free survival, and OS when compared with low DDX1 expression in node-negative and early-stage patients with breast cancer [33]. The gene discussed is DDX1; the disease is breast carcinoma.